Park S - Search Results

1

Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients.

Park S, Kelaidi C, Sapena R, Vassilieff D, Beyne-Rauzy O, Coiteux V, Vey N, Ravoet C, Cheze S, Rose C, Legros L, Stamatoullas A, Escoffre-Barbe M, Guerci A, Chaury MP, Fenaux P, Dreyfus F. Park S, et al. Leuk Res. 2010 Nov;34(11):1430-6. doi: 10.1016/j.leukres.2010.05.030. Epub 2010 Jun 26. Leuk Res. 2010. PMID: 20580086

2

Pure red cell aplasia associated with myelodysplastic syndromes.

Park S, Merlat A, Guesnu M, Picard F, Viguié F, Vassilieff D, Dreyfus F. Park S, et al. Leukemia. 2000 Sep;14(9):1709-10. doi: 10.1038/sj.leu.2401833. Leukemia. 2000. PMID: 10995022 No abstract available.

3

Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.

Park S, Picard F, Azgui Z, Viguie F, Merlat A, Guesnu M, Leblond V, Dreyfus F. Park S, et al. Leuk Res. 2002 May;26(5):423-9. doi: 10.1016/s0145-2126(01)00146-1. Leuk Res. 2002. PMID: 11916513

4

Erythroleukemia: a need for a new definition.

Park S, Picard F, Dreyfus F. Park S, et al. Leukemia. 2002 Aug;16(8):1399-401. doi: 10.1038/sj.leu.2402549. Leukemia. 2002. PMID: 12145675 Review.

5

Erythroleukaemia and RAEB-t: a same disease?

Park S, Picard F, Guesnu M, Maloum K, Leblond V, Dreyfus F. Park S, et al. Leukemia. 2004 Apr;18(4):888-90. doi: 10.1038/sj.leu.2403316. Leukemia. 2004. PMID: 14973506 No abstract available.

6

Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients.

Park S, Abad S, Tulliez M, Monnet D, Merlat A, Gyan E, Bouscary D, Dreyfus F, Grimaldi D, Dhote R, Rollot F, Kelaïdi C, Nazal EM, Brézin AP, Blanche P. Park S, et al. Medicine (Baltimore). 2004 Jul;83(4):223-232. doi: 10.1097/01.md.0000134850.35118.46. Medicine (Baltimore). 2004. PMID: 15232310 Free article.

7

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.

Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, Calmus Y, Podevin P, Bouscary D, Sogni P, Blanche P, Dreyfus F. Kelaidi C, et al. Among authors: park s. Leukemia. 2004 Oct;18(10):1711-6. doi: 10.1038/sj.leu.2403443. Leukemia. 2004. PMID: 15284859

8

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.

Claessens YE, Park S, Dubart-Kupperschmitt A, Mariot V, Garrido C, Chrétien S, Dreyfus F, Lacombe C, Mayeux P, Fontenay M. Claessens YE, et al. Among authors: park s. Blood. 2005 May 15;105(10):4035-42. doi: 10.1182/blood-2004-08-3166. Epub 2005 Jan 27. Blood. 2005. PMID: 15677568 Free article.

9

High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study.

Mannone L, Gardin C, Quarre MC, Bernard JF, Vassilieff D, Ades L, Park S, Vaultier S, Hamza F, Beyne-rauzy MO, Cheze S, Giraudier S, Agape P, Legros L, Voillat L, Dreyfus F, Fenaux P; Groupe Francais des Myelodysplasies. Mannone L, et al. Among authors: park s. Br J Haematol. 2006 Jun;133(5):513-9. doi: 10.1111/j.1365-2141.2006.06070.x. Br J Haematol. 2006. PMID: 16681638 Free article. Clinical Trial.

10

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.

Tamburini J, Elie C, Bardet V, Chapuis N, Park S, Broët P, Cornillet-Lefebvre P, Lioure B, Ugo V, Blanchet O, Ifrah N, Witz F, Dreyfus F, Mayeux P, Lacombe C, Bouscary D. Tamburini J, et al. Among authors: park s. Blood. 2007 Aug 1;110(3):1025-8. doi: 10.1182/blood-2006-12-061283. Epub 2007 Apr 10. Blood. 2007. PMID: 17426258 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63,094 results

Search Page